<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: November 7, 2000
----------------
BIOQUAL, INC.
-------------
State of Delaware 0-13527 13-3078199
------------------------------- ----------- ------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File No.) Identification No.)
9600 Medical Center Drive, Rockville, Maryland 20850-3336
---------------------------------------------- ----------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (301) 251-2801
--------------
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant.
--------
Effective November 7, 2000, BIOQUAL, Inc. (the "Company") has terminated the
engagement of Deloitte & Touche LLP as its independent public accountants. On
the same day, the Company retained Aronson, Fetridge & Weigle as its public
accountants. The engagement of Aronson, Fetridge & Weigle was recommended by
the Audit Committee of the Company's Board of Directors and approved by the
Board of Directors (the "Board").
The audit reports by Deloitte & Touche LLP on the Company's financial statements
for each of the last two fiscal years ended May 31, 1999 and May 31, 2000,
respectively, did not contain an adverse opinion or a disclaimer of opinion and
were not qualified or modified as to uncertainty, audit scope, or accounting
principles.
In connection with the audits of the Company's financial statements for each of
the two fiscal years ended May 31, 1999 and May 31, 2000, respectively, and in
the subsequent interim period, there have been no disagreements between the
Company and Deloitte & Touche LLP on any matters of accounting principles or
practices, financial statement disclosure, or auditing scope and procedures
which, if not resolved to the satisfaction of Deloitte & Touche LLP would have
caused it to make reference to the subject matter of the disagreement in
connection with its reports on the audited financial statements.
A letter from Deloitte & Touche LLP is attached as Exhibit 16 to this Form 8-K
and incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
-------
c. Exhibits.
(16) Letter from Deloitte & Touche LLP regarding change in certifying
accountant
2
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOQUAL, Inc.
Date: November 13, 2000 By: /s/ David A. Newcomer
----------------- ----------------------
David A. Newcomer
Chief Financial Officer
3
<PAGE>
Exhibits
(16) Letter from Deloitte & Touche LLP regarding change in certifying
accountant
4
